AI assistant
Sending…
Tempest Therapeutics, Inc. — Director's Dealing 2016
Jun 3, 2016
34632_dirs_2016-06-03_be98f2c3-fab5-4270-b1ad-db1cc1459519.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2016-06-01
Reporting Person: Malley Thomas (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-01 | Common Stock | A | 50000 | $7.00 | Acquired | 176970 | Direct |
More from Tempest Therapeutics, Inc.
Board/Management Information
2026
Jun 4
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 29
Delisting Announcement
2026
May 22
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Regulatory Filings
2026
May 6
Capital/Financing Update
2026
Apr 10
Capital/Financing Update
2026
Apr 10